DSG3 and acquired polycythemia vera: These findings suggest that gender and specific baseline PDAI and anti-Dsg3 antibody titers may play a critical role in predicting the persistence of anti-Dsg3 antibodies in patients with PV following CR, which may have implications for ongoing monitoring and management strategies in this population.